Taffic is a once-daily single-tablet treatment for HIV-1 infection that combines bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking HIV replication in the body—bictegravir inhibits the integrase enzyme, while emtricitabine and tenofovir alafenamide stop reverse transcriptase activity. This helps reduce viral load, improve CD4 cell count, and lower the risk of ... https://www.taffic.in/healthcare-professionals